Literature DB >> 19564584

Long-term effects of pallidal deep brain stimulation in tardive dystonia.

D Gruber1, T Trottenberg, A Kivi, T Schoenecker, U A Kopp, K T Hoffmann, G-H Schneider, A A Kühn, A Kupsch.   

Abstract

OBJECTIVE: High-frequency stimulation of the globus pallidus internus (GPi) is a highly effective therapy in primary dystonia. Recent reports have also demonstrated almost immediate improvement of motor symptoms in patients with tardive dystonia after pallidal deep brain stimulation (DBS). Here, we show the long-term effect of continuous bilateral GPi DBS in tardive dystonia on motor function, quality of life (QoL), and mood.
METHODS: Nine consecutive patients undergoing DBS for tardive dystonia were assessed during continuous DBS at 3 time points: 1 week, 3 to 6 months, and last follow-up at the mean of 41 (range 18-80) months after surgery using established and validated movement disorder and neuropsychological scales. Clinical assessment was performed by a neurologist not blinded to the stimulation settings.
RESULTS: One week and 3 to 6 months after pallidal DBS, Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) motor scores were ameliorated by 56.4 +/- 26.7% and 74.1 +/- 15.8%, BFMDRS disability scores by 62.5 +/- 21.0% and 88.9 +/- 10.3%, and Abnormal Involuntary Movement Scale (AIMS) scores by 52.3 +/- 24.1% and 69.5 +/- 27.6%, respectively. At last follow-up, this improvement compared with the presurgical assessment was maintained as reflected by a reduction of BFMDRS motor scores by 83.0 +/- 12.2%, BFMDRS disability scores by 67.7 +/- 28.0%, and AIMS scores by 78.7 +/- 19.9%. QoL improved significantly in physical components, and there was a significant improvement in affective state. Furthermore, cognitive functions remained unchanged compared with presurgical status in the long-term follow-up. No permanent adverse effects were observed.
CONCLUSION: Pallidal deep brain stimulation is a safe and effective long-term treatment in patients with medically refractory tardive dystonia.

Entities:  

Mesh:

Year:  2009        PMID: 19564584     DOI: 10.1212/WNL.0b013e3181aaea01

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

Review 2.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 3.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

4.  Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia.

Authors:  Sara Meoni; Mateusz Zurowski; Andres M Lozano; Mojgan Hodaie; Yu-Yan Poon; Melanie Fallis; Valerie Voon; Elena Moro
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

Review 5.  [Deep brain stimulation for hyperkinetic movement disorders].

Authors:  M M Reich; J Volkmann
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

6.  Bilateral Pallidal Stimulation Improves Chorea in Antiphospholipid Antibody Syndrome With Oral Anticoagulation.

Authors:  Christoph Schrader; Michelle Aumüller; Götz Lütjens; Assel Saryyeva; Hans-Holger Capelle; Joachim K Krauss
Journal:  Mov Disord Clin Pract       Date:  2015-03-28

Review 7.  Arching deep brain stimulation in dystonia types.

Authors:  Han-Joon Kim; Beomseok Jeon
Journal:  J Neural Transm (Vienna)       Date:  2021-03-19       Impact factor: 3.575

Review 8.  [Deep brain stimulation for movement disorders].

Authors:  F Steigerwald; J Volkmann
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

Review 9.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 10.  Update on treatments for dystonia.

Authors:  D Cristopher Bragg; Nutan Sharma
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.